Patient-specific network modeling to personalize neurostimulation treatment in depression

QR Code

Patient-specific network modeling to personalize neurostimulation treatment in depression

Enregistré dans:

Détails bibliographiques
Auteur principal:	Zelma Kiss
Format:	article
Langue:	EN
Publié:	Elsevier 2021
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Accès en ligne:	https://doaj.org/article/3db371f65abe48e88e92a4352ec0b5a8
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Use of the Virtual Brain to target networks in treatment resistant depression
par: Sora An, et autres
Publié: (2021)

Combining EEG and MRI data to personalize neurostimulation for focal epilepsy; an open-source software implementation
par: Steven Beumer, et autres
Publié: (2021)

The effect of expertise, training and neurostimulation on sensory-motor skill in esports
par: Mark Campbell, et autres
Publié: (2021)

How to use multimodal neuroimaging to personalize rTMS parameters for depression treatment
par: Debby Klooster, et autres
Publié: (2021)

Clinical utility of implantable neurostimulation devices as adjunctive treatment of uncontrolled seizures
par: Cox JH, et autres
Publié: (2014)

Identification of a Personalized Intracranial Biomarker of Depression and Response to DBS Therapy
par: Adam Frank, et autres
Publié: (2021)

A comparison of symptom-specific resting state functional connectivity biomarkers of 10 Hz and iTBS-rTMS in treatment-resistant depression
par: Katharine Dunlop, et autres
Publié: (2021)

A 6-month naturalistic study of depression and insomnia using transcranial magnetic stimulation (TMS) in 100 patients with treatment-resistant depression demonstrating response and durability
par: Debra Stultz, M.D., et autres
Publié: (2021)

Effectiveness of unilateral vs. bilateral rTMS treatment on suicidal ideation in patients with depression and comorbid anxiety
par: Victoria Middleton, et autres
Publié: (2021)

Predictors of clinical response after rTMS treatment of patients suffering from drug-resistant depression
par: Aurélie Lacroix, et autres
Publié: (2021)

Relationship between dose and duration of treatment response in severely treatment-resistant depression patients treated with accelerated intermittent theta bust stimulation
par: Ian Kratter, et autres
Publié: (2021)

Repetitive transcranial magnetic stimulation (rTMS) in the treatment of bipolar depression
par: Tomáš Novák, et autres
Publié: (2021)

Prolonged intermittent theta burst stimulation in the treatment of major depressive disorder
par: Clémence Noiseux, et autres
Publié: (2021)

Lack of progression of beta dynamics after long‐term subthalamic neurostimulation
par: Ross W. Anderson, et autres
Publié: (2021)

Lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression
par: J. Blair Price, et autres
Publié: (2021)

Rumination: relationships with repetitive transcranial magnetic stimulation treatment of major depressive disorder
par: Stephanie A. Chu, et autres
Publié: (2021)

Comparison of clinical outcomes with left unilateral and sequential bilateral transcranial magnetic stimulation treatment of major depressive disorder in a large patient registry
par: Harold Sackeim
Publié: (2021)

Simultaneous aerobic exercise and rTMS for treatment-resistant depression – a case report
par: Catherine VanDerwerker, et autres
Publié: (2021)

Vitamin D and the risk of treatment-resistant and atypical depression: A Mendelian randomization study
par: Ryan Arathimos, et autres
Publié: (2021)

Optimizing TMS coil placement for engagingindividual-specific functional network topology
par: Charles Lynch, et autres
Publié: (2021)

The effects of vagus nerve stimulation on the course and outcomes of patients with bipolar disorder in a treatment-resistant depressive episode: a 5-year prospective registry
par: R. Hamish McAllister-Williams, et autres
Publié: (2021)

Combined bilateral frontal + cerebellar tDCS as a potential intervention for treatment-resistant depression
par: Michelangelo Dini, et autres
Publié: (2021)

Brainmarker-I: a transdiagnostic EEG biomarker predicting remission to various depression and ADHD treatments
par: Helena Voetterl, et autres
Publié: (2021)

Comorbid personality disorders among patients with depression
par: Wongpakaran N, et autres
Publié: (2015)

Heartbeat evoked potential in major depressive disorder: Differential treatment prediction for antidepressant medication and rTMS
par: Lauren Zwienenberg, et autres
Publié: (2021)

Letter to the editor regarding “Accelerated theta burst stimulation for the treatment of depression: A randomised controlled trial”
par: Abdul-Rahman Hudaib, M.D., MBiostat
Publié: (2021)

Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
par: Manoj K. Doss, et autres
Publié: (2021)

Peripheral immune cell reactivity and neural response to reward in patients with depression and anhedonia
par: Sara Costi, et autres
Publié: (2021)

Proteomics analysis of the gut–brain axis in a gut microbiota-dysbiosis model of depression
par: Yiyun Liu, et autres
Publié: (2021)

Efficacy of add-on bilateral transcranial magnetic stimulation with a double-cone coil in patients with treatment resistant depression and comorbid anxiety: Evidence from real-world clinical practice.
par: Michael Kabar, et autres
Publié: (2021)

Multi-target repetitive transcranial magnetic stimulation (rTMS) protocol for the treatment of comorbid depression and chronic pain
par: Juliana Corlier, et autres
Publié: (2021)

Clinical effectiveness of 1 Hz/20 Hz bilateral rTMS treatment in adolescents with major depressive disorder
par: Paul Croarkin, et autres
Publié: (2021)

Changes in brain functional connectivity following theta burst stimulation augmented with cognitive training for the treatment of youth depression
par: Benjamin Schwartzmann, et autres
Publié: (2021)

Treatment of refractory obsessive-compulsive disorder with comorbid major depression with sequential multi-locus transcranial magnetic stimulation
par: Reza Tadayonnejad, et autres
Publié: (2021)

The influence of sample and treatment characteristics on the efficacy of repetitive transcranial magnetic stimulation in depression: a meta-analysis and meta-regression
par: Iris Dalhuisen, et autres
Publié: (2021)

App-based ecological momentary assessment and symptom-adaptive scheduling of TMS maintenance treatments to prevent depressive episode recurrence
par: Linda Carpenter, et autres
Publié: (2021)

Identifying Resonant Frequencies for Treatment of Major Depressive Disorder (MDD) using repetitive Transcranial Magnetic Stimulation (rTMS)
par: Juliana Corlier, et autres
Publié: (2021)

A case study of low-intensity focused ultrasound for treatment-resistant generalized anxiety disorder and major depressive disorder
par: Maggie Zielinski, et autres
Publié: (2021)

Cranial electrotherapy stimulation after transcranial magnetic stimulation for maintenance of improvement in treatment-resistant depression: a pilot study
par: Sandeep Vaishnavi, et autres
Publié: (2021)

Individual interregional perfusion patterns predict response and remission to aiTBS treatment in medication resistant depression: the influence of Behavioral Inhibition
par: Guo-Rong Wu, et autres
Publié: (2021)